Aspen Neuroscience, Inc. (ASPE) Stock
Key stats
- Market cap
- $401.87M
- Price / Earnings ratio
- -6.0x
- EPS (TTM)
- -$6.01
- Volume
- Loading
- 52-week high
- $14.90
- 52-week low
- $11.20
Source: third-party data provider, as of November 13, 2026
Recent news
No recent news
Analyst ratings
No analyst data available
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
About Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. is a leading, clinical-stage regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases with high unmet medical need. The company’s lead product candidate, sasineprocel, is an investigational single-dose, autologous iPSC-based cell therapy being evaluated for the treatment of Parkinson’s disease (PD).
Fundamentals
Valuation
Trading
Source: third-party data provider, as of November 13, 2026
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.0 | +6.0 |



